Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $105,984 - $229,632
18,400 Added 131.43%
32,400 $224,000
Q4 2022

May 24, 2023

SELL
$8.86 - $25.04 $163,024 - $460,736
-18,400 Reduced 56.79%
14,000 $143,000
Q4 2022

Feb 14, 2023

BUY
$8.86 - $25.04 $124,039 - $350,560
14,000 New
14,000 $144,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $721M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.